Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF
Clinical and Experimental Medicine · 2024
DOI: 10.1007/s10238-024-01467-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Medicine, 2024. Verfasst von Lunhui Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Granulocyte Colony-Stimulating Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
The Sysmex XN series haematopoietic progenitor cell (XN-HPC) is a novel tool for assessing stem cell yield before allogeneic haematopoietic stem cell transplantation. This study aimed to establish a reference interval (RI) for XN-HPC in peripheral blood allogeneic transplant donors following granulocyte colony-stimulating factor (G-CSF) stimulation and determine its clinical significance. All specimens were analysed using Sysmex XN-20. Samples were collected and analysed using non-parametric percentile methods to define the RIs. Quantile regression was used to explore the dependency of the RIs on sex and age. Samples were included in clinical decision limits for apheresis based on receiver operating characteristic curve analysis. The non-parametrically estimated RI for XN-HPC was 623.50 (90% confidence interval [CI90%] 510.00-657.00) to 4,144.28 (CI90% 3,761.00-4,547.00). The RIs for the XN-HPC were not age-dependent but were sex-dependent. The RI for males was 648.40 (CI90% 582.00-709.00)-4,502.60 (CI90% 4,046.00-5,219.00) and for females was 490.90 (CI90% 311.00-652.00)-3,096.90 (CI90% 2,749.00-3,782.00). Comparisons based on XN-HPC values between the poor and less-than-optimal groups, good and less-than-optimal groups, and good and non-good groups had areas under the curve of 0.794 (P 5318 < 106/L indicated 100% mobilisation effectiveness. We established an RI for XN-HPC in peripheral blood allogeneic transplant donors following G-CSF stimulation and determined clinical decision thresholds for mobilisation efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, China.
- Department of Epidemiology and Statistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking, Union Medical College, Beijing, China.
- Tianjin Institutes of Health Science, Tianjin, China. zhuguoqing@ihcams.ac.cn.
- Tianjin Institutes of Health Science, Tianjin, China. jiangerlie@ihcams.ac.cn.
- Tianjin Institutes of Health Science, Tianjin, China. xiayonghui@ihcams.ac.cn.
Förderung
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
Zitieren
APA
Huang, L., Lin, B., Mu, Y., Li, Y., Chen, M., Zhou, Y., Zhu, G., Jiang, E., & Xia, Y. (2024). Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-024-01467-0
Vancouver
Huang L, Lin B, Mu Y, Li Y, Chen M, Zhou Y, et al. Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF. Clinical and Experimental Medicine. 2024. doi:10.1007/s10238-024-01467-0
BibTeX
@article{Huang2024,
author = {Huang, Lunhui and Lin, Binbin and Mu, Yueyi and Li, Yong and Chen, Miao and Zhou, Yunxia and Zhu, Guoqing and Jiang, Erlie and Xia, Yonghui},
title = {Sysmex XN-HPC: study of reference intervals and clinical decision limits in healthy allogeneic donors mobilised with G-CSF},
journal = {Clinical and Experimental Medicine},
year = {2024},
doi = {10.1007/s10238-024-01467-0}
}
EUVIMED